ConductScience.org, home

Paper17547475

Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.

Tytgat GN. Drugs, 2007. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Papers, record 17547475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17547475

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain.
PubMed
Journal
Drugs
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
4.12
iCite
Revised in PubMed
2022-03-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tytgat GNGuido N

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Butylscopolammonium BromideMajor topic
ColicMajor topic
Animals
Clinical Trials as Topic
Humans
Molecular Structure
Muscarinic Antagonists
Parasympatholytics
Treatment Outcome

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110896640Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.Ann Intern Med2000https://conductscience.org/library/papers/10896640PubMed
216842469Prevalence and management of abdominal cramping and pain: a multinational survey.Aliment Pharmacol Ther2006https://conductscience.org/library/papers/16842469PubMed
316817918Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain.Aliment Pharmacol Ther2006https://conductscience.org/library/papers/16817918PubMed
44390607The actions of atropine, tropenziline and N-butyl hyoscine bromide on the isolated distal colon of the guinea-pig: a comparison of their activities and mechanisms of action.J Pharm Pharmacol1969https://conductscience.org/library/papers/4390607PubMed
515606387Meta-analysis: The treatment of irritable bowel syndrome.Aliment Pharmacol Ther2004https://conductscience.org/library/papers/15606387PubMed
612425586Systematic review on the management of irritable bowel syndrome in North America.Am J Gastroenterol2002https://conductscience.org/library/papers/12425586PubMed
716445300Costs of irritable bowel syndrome in the UK and US.Pharmacoeconomics2006https://conductscience.org/library/papers/16445300PubMed
8328327A double-blind comparative study of the inhibitory effect of intraduodenally administered hyoscine-N-butylbromide on human duodenal motility.J Int Med Res1977https://conductscience.org/library/papers/328327PubMed
94679187[Effect of rectally applied hyoscin-N-butylbromide on small intestine motility].Arzneimittelforschung1972https://conductscience.org/library/papers/4679187PubMed
106147311Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog.Int J Clin Pharmacol Ther Toxicol1984https://conductscience.org/library/papers/6147311PubMed
1115256832Quality of life and illness costs in irritable bowel syndrome.Digestion2004https://conductscience.org/library/papers/15256832PubMed
124885158[Testing of orally administered spasmolytics demonstrated by the effect of hyoscine-N-butylbromide on gastric motility].Arzneimittelforschung1968https://conductscience.org/library/papers/4885158PubMed
1315862938Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.Gastroenterol Clin North Am2005https://conductscience.org/library/papers/15862938PubMed
1410877233Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact.Dig Dis Sci2000https://conductscience.org/library/papers/10877233PubMed
1515243388Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.Gastroenterol Clin Biol2004https://conductscience.org/library/papers/15243388PubMed
166526796Different therapeutic regimens in irritable bowel syndrome.J Assoc Physicians India1984https://conductscience.org/library/papers/6526796PubMed
1711207510Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome.Aliment Pharmacol Ther2001https://conductscience.org/library/papers/11207510PubMed
1832949Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk.Br Med J1979https://conductscience.org/library/papers/32949PubMed
197284686Oral hyoscine butylbromide does not alter the pattern of small intestinal motor activity.Br J Pharmacol1981https://conductscience.org/library/papers/7284686PubMed
205820047[Inhibition of small intestine motility by orally administered hyoscine-N-butylbromide].Arzneimittelforschung1969https://conductscience.org/library/papers/5820047PubMed

See all 31 referencesDownload CSV of references

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
42952977Hyoscine N-butylbromide administration before colostrum feeding improves passive transfer in dairy calves.Front Vet Sci2026https://conductscience.org/library/papers/42952977PubMed
42773320Pharmacotherapy of Irritable Bowel Syndrome with Constipation in Children: An Update on Clinical Progress and Successes.Drugs2026https://conductscience.org/library/papers/42773320PubMed
41866875Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome.Turk J Gastroenterol2025https://conductscience.org/library/papers/41866875PubMed
41482625A real-world study to describe the effectiveness and usage patterns of hyoscine butylbromide plus tablets in patients with dysmenorrhoea.Womens Health (Lond)2026https://conductscience.org/library/papers/41482625PubMed
41257808Holistic approach to dysmenorrhea management: Integrating pharmacological and non-pharmacological interventions for improved women's health in the Middle East and Africa.BMC Womens Health2025https://conductscience.org/library/papers/41257808PubMed
41155589Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-b]thiazole-Derivatives from Calcium Entry Blockers to a New Approach for Gut Dysfunctional Motility.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155589PubMed
40839003Antispasmodic activity of a series of cyclic imides (phthalimides) derivatives.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/40839003PubMed
40655474Efficacy of herbal medicine (Thatbunjob) in the treatment of foodborne illness: A placebo-controlled, randomized trial.Integr Med Res2025https://conductscience.org/library/papers/40655474PubMed
40371460Acid/Base-Responsive Circularly Polarized Luminescence Emitters with Configurationally Stable Nitrogen Stereogenic Centers.Adv Mater2025https://conductscience.org/library/papers/40371460PubMed
40364041A Comprehensive Review of the Effects of Hyoscine Butylbromide in Childhood.J Clin Med2025https://conductscience.org/library/papers/40364041PubMed
40331189Effect of propinox and pinaverium bromide on ex vivo colonic motor patterns and their synergistic effect with hyoscine butyl bromide.Front Pharmacol2025https://conductscience.org/library/papers/40331189PubMed
40308456Anticholinergic agents and impaired cognitive function: is there a risk for patients with irritable bowel syndrome?Ther Adv Gastroenterol2025https://conductscience.org/library/papers/40308456PubMed
40303371Real-world effects of hyoscine butylbromide combined with paracetamol in women with dysmenorrhea: a patient survey.Front Med (Lausanne)2025https://conductscience.org/library/papers/40303371PubMed
39875349Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson's disease.Gut Microbes2025https://conductscience.org/library/papers/39875349PubMed
39473756Hyoscine-n-butylbromide in treating abdominal pain caused by gastroenteritis: a double-blind randomized placebo-controlled study.Turk J Med Sci2024https://conductscience.org/library/papers/39473756PubMed
39199604Antispasmodic Agents in Magnetic Resonance Imaging of the Urinary Bladder-A Narrative Review.Cancers (Basel)2024https://conductscience.org/library/papers/39199604PubMed
39042346Subchronic administration of scopolamine reverses UCMS-induced behavior in mice via eEF2 protein dephosphorylation.Pharmacol Rep2024https://conductscience.org/library/papers/39042346PubMed
38188926Provider-reported use of butylscopolamine in gastrointestinal endoscopy in Germany.Endosc Int Open2024https://conductscience.org/library/papers/38188926PubMed
37576742Comparative evaluation of the potential anti-spasmodic activity of Piper longum, Piper nigrum, Terminalia bellerica, Terminalia chebula, and Zingiber officinale in experimental animals.Saudi Pharm J2023https://conductscience.org/library/papers/37576742PubMed
37171269Assessment of T2-weighted Image Quality at Prostate MRI in Patients with and Those without Intramuscular Injection of Glucagon.Radiol Imaging Cancer2023https://conductscience.org/library/papers/37171269PubMed

See all 56 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17547475

GET https://conductscience.org/api/papers/v1/17547475/references?page=2